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Cultures of synovial explants from patients with rheumatoid arthritis release 
large quantities of collagenase and prostaglandins into the media (1-3).  The 
collagenase can degrade undenatured collagens such as those of the joint struc- 
tures, and the prostaglandins, predominantly PGE2,  may have several effects 
including promoting bone resorption (3, 4) and increasing local vascular dilata- 
tion and permeability (5). The cells that comprise the rheumatoid synovium can 
be dispersed using proteolytic enzymes, and adherent cells obtained that lack 
macrophage markers but produce typical mammalian collagenase for prolonged 
periods  (weeks  to  >18  mo).  Early  in  culture  these  cells  also  release  large 
amounts of PGE2,  but secretion of PGE2  declines rapidly after  7-10  days in 
culture, while collagenase production persists. Collagenase levels decline with 
age in culture and after passage of  the cells by trypsinization and dilution (6). 
Since regions of rheumatoid synovium beneath the lining cell layer usually 
contain large numbers of mononuclear cells (7), we reasoned, based on the work 
of others (8,  9),  that lymphocytes and mononuclear cells might modulate the 
function of other synovial cells. Human mononuclear cells in culture produce a 
soluble factor which can stimulate the production of collagenase by the adherent 
rheumatoid synovial cells (10). We describe here the concomitant stimulation of 
PGE2 production by the adherent synovial cells by a factor from mononuclear 
cells.  The factor which stimulates PG~  production is  similar in  molecular 
weight to that which stimulates collagenase production. 
Materials  and Methods 
Synovial  Cell Culture.  Isolated adherent rheumatoid synovial cells (ASC) were prepared by 
proteolytic dispersion of rheumatoid arthritic synovectomy specimens and cultures maintained as 
described previously (6, 10). Cells were passaged after treatment with trypsin-EDTA and split 1:2 
or 1:4. For most experiments reported here ASC were plated in 6-cm diameter polystyrene Petri 
dishes at 50 x  104 cells per dish (2 ml medium) or in trays containing 24 wells of 16-mm diameter 
(0.3 ml medium) usually at 5 or 10  x  104 cells per well (10). 
Lymphocyte Supernatant  Media (LM).  Heparinized venous blood from normal persons or pa- 
tients  with  classical  rheumatoid  arthritis  was  used  as  a  source  of lymphocytes  which were 
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separated  on sodium  metrizoate/Ficoll gradients  (Nyegaard  and  Co.,  Oslo, Norway)  (11). The 
mononuclear cells were cultured at 37°C, in an atmosphere of 95% air and 5% CO2, at 2 ×  106 cells/ 
ml in 6-cm diameter polystyrene Petri dishes in Dulbecco's modification of Eagle's medium with 
10% fetal bovine serum (DMEM 10% FCS). After 24 h  the nonadherent  lymphocytes were sepa- 
rated from  the  adherent  monocytes,  centrifuged,  resusponded  in  DMEM  10%  FCS, and  incubated 
for a further  3 days with or without phytehemagglutinin (PHA) (Wellcome Research Labora- 
tories,  Kent,  England).  Although most  monocyte-macrophages  were  removed  by  this  procedure,  it 
was  not  determined  to  what  extent  the  nonadherent  population,  here  referred  to  as  lymphocytes, 
was still  contaminated by monocyte-macrophages. The lymphocyte-free  supornatant medium 
(LM) prepared  by  centrifugation  (300g  for  10  rain)  was  used  as  a  source  of  the  stimulating  factor. 
Chromatography of  LM.  Before  gel filtration,  cell-free  supernatant  media from 9 unstimu- 
fated  lymphocyte  cultures  and 10  cultures  of  lymphocytes  stimulated  with  PHA were pooled  (total 
vol 450 ml).  Cells  were from both  normal and rheumatoid subjects.  The pooled  medium was 
dialyzed  for 3 days against  100 volumes of  0.04% sodium azide  in distilled  water followed  by 
distilled  water alone.  The retentate  was removed, freeze-dried,  and kept  at -30°C until  use.  A 
solution (2.5  ml) of  the dried  powder in the column buffer  (60 mg/ml) was then applied  to a 
calibrated  column (36.5  × 2.5  cm) of  Ultrogel  AcA 54 (LKB Instruments,  Inc.,  Rockville,  Md.), 
equilibrated,  and eluted  with  buffer  (10  mM Tris-HCl,  pH 7.5,  165  mM NaCl, and 5 mM CaCl2). 
The  eluant  fractions  were diluted  in  DMEM  10% FCS and  sterilized  by  Millipore  filtration  before 
incubation  with  ASC. 
Assays.  Prostaglandins  in culture  media were measured by radioimmunoassay utilizing  an 
antiserum  to  PGF_~  (12)  kindly  provided  by Dr. L. Levine  Brandeis  University,  Waltham, Mass. 
Prostaglandins from representative  culture  media were further  characterized  by thin-layer 
chromatography (13).  Collagenase  activity  was assayed using ['4C]glycine-labeled  guinea  pig 
skin collagen after  activation  with trypsin-L-(tosylamido  2-phenyl)ethylchloromethyl  ketene 
(Worthington  Biochemical  Corp.,  Freehold,  N. J.)  as  previously  described  (6,  10). 
Cell  Counting  and [3H]Thymidine Uptake. Cells  were counted  using  a Coulter  counter  (Coul- 
ter  Electronics  Inc.,  Hialeah,  Fla.).  Lymphocyte [~H]thymidine  uptake was measured with and 
without  PHA (5 ~g/ml)  by adding 5 pCi/0.5 x 10  s  cells/0.2  ml medium for  the last  16  h of  a 72  h 
incubation  period.  Isolation  of  ~H-DNA was performed  on  glass  fiber  strips  after  filtration  using 
the MASH-If apparatus  (Microbiological  Associates,  Bethesda,  Md.). 
Results 
The response of production of PGE2  and collagenase by ASC  to LM  in the 
presence and absence of  indomethacin is shown in Table I. Marked stimulation 
by LM  of  both PGE2 and collagenase was observed in  the absence of  indometha- 
cin. Whereas indomethacin blocked production of  PGE2, this drug had no effect 
on total collagenase  production.  Cellular proliferation was decreased in the 
presence of  LM  but was increased when indomethacin was present in  addition to 
LM. 
It was possible to establish a dose-response for production of PGE2  (Fig. 1  A) 
and collagenase (Fig. 1  B) by ASC  stimulated by LM, with and without indo- 
methacin. At all  doses of  LM, indomethacin blocked PGE2 production but did  not 
affect total  collagenase production. LM  prepared from cultures of  lymphocytes 
which had been incubated in the presence of PHA  had a greater stimulatory 
effect on production  of both  PG~  and  collagenase  by ASC  than  LM  from 
cultures incubated without PHA  (Figs. 2  A  and 2 B). PHA  alone at concentra- 
tions  present in diluted LM  incubated  directly with ASC  had  no effect on 
production of  either PGE2 or collagenase. 
Medium  pooled from several lymphocyte  cultures was chromatographed  on 
columns of  Ultrogel AcA 54 as shown in  Fig. 3. The peaks of  stimulatory activity 
for both collagenase  and PGE2  were similar and were eluted in the region 
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TABLE  I 
Inhibition by Indomethacin of PGE2 Production by Adherent Rheumatoid Synovial Cells 
(ASC) 
Cell number x 
10-41well 
PGE2  Collagenase 
ng/well  ng/10  e ceils  U/well  U/IO  e cells 
ASC  11.2 ±  0.3  0.30  ±  0.03  9.35  ±  1.27  0.020  ±  0.003  0.210 ±  0.070 
ASC  +  indomethacin,  14 ~M  11.5 -+ 0.3  0.25 ±  0.01  7.21  ±  0.07  0.030  ±  0.003  0.210 ±  0.005 
ASC  ±  LM  9.2  ±  0.2  26.79  ±  1.43  946.20  ±  115.05  4.91  ±  0.59  54.58  ±  6.21 
ASC  +  LM  +  indomethacin,  14/zM  14.3 -+  0.6  0.17 ±  0.91  5.48 ±  0.10  7.80  ±  0.57  56.34  ±  4.05 
ASC in the second passage were plated at ~9 x  I(P cells per well 5 days before incubation with LM obtained from lymphocytes cultured from 
a  normal subject.  LM (0.060 ml) was added to each  well containing 0.3 ml of total medium.  Each value is the mean  ¢  SEM for four wells. 
Cells  were  counted  at  the  end  of the  incubation  period  of 3  days.  Unit  (U)  of collagenaas  activity  is that  which  solubilizes  1  ~g  of 
reconstituted  collagen fibrils/rain at 37°C. 
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FIG.  1.  Production of PGE2 (A) and collagenase (B) by ASC as a function of the volume of 
added lymphocyte medium.  Lymphocytes from a  normal subject were incubated at 2  x  10  s 
cells/ml  for  3  days,  at  37°C.  The  cell-free  medium  was  added  to  ASC,  plated  5  days 
previously in multi-well trays at -9  x  104 cells per well, total vol 0.3 ml, and incubation 
continued for 3 days at 37°C.  Open symbols indicate absence and closed symbols presence of 
14 ~tM indomethacin. 
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FIG.  2.  Production of PGE2  (A) and collagenase  (B) by synovial cells as a  function of the 
volume of added lymphocyte medium.  Lymphocytes from a  normal subject were incubated 
without (D,  O) and with (m,  O) PHA, 5  ~g/ml,  at 2  x  106 cells/ml for 3 days, at 37°C. The 
cell-free medium was added to ASC plated in multi-well trays 7 days previously at -9  x  104 
cells per well, total vol 0.3 ml, and incubation continued for 3 days at 37°C. 1402  DAYER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Fro.  3.  Effect on ASC  of lymphocyte culture  medium  after gel filtration.  Concentrated 
pool of lymphocyte  medium  was applied to calibrated column  of Ultrogel AcA 54 and eluant 
fractions  incubated  with ASC plated at -9  ×  104 cells  per well as described. After 3 days the 
media were assayed for collagenase (e) and PGE2 (©). Arrows indicate elution position  of 
calibration markers: CAT, catalase; BSA, bovine serum albumin; CARB. ANH., carbonic 
anhydrase; RIBON. A., ribonuclease A; Ph.R., phenol red. 
gest an approximate molecular weight of  the stimulating  factor of 10,000-20,000. 
The addition of  lymphocyte media increased PGE release by all 20 rheumatoid 
synovial cell cultures so far tested. In some synovial cell cultures, even after 
several  passages,  exposure  to  cell-free LM increased PGE  concentrations to 
levels approaching those found in freshly isolated synovial cells (-1,000 rig/106 
cells/day)  (6). The  variability  in  response  probably  depended  upon  several 
factors  including passage  and  dilution  of ASC  and  the  source  of the  LM. 
However, each of the 45 lymphocyte  preparations so far tested (from control and 
rheumatoid subjects) stimulated PGE production by synovial cells. 
Prostaglandins from representative stimulated culture media were extracted 
with ethyl acetate and separated by thin-layer chromatography (13). The areas 
corresponding to  PGE2  and  to  PGA~  and  PGBz  were  identified by  tritiated 
marker  compounds,  and  eluted from the  chromatographic strips.  PGE~  was 
found, in four separate stimulated cultures, to account for 85-95% of  the total PG 
assayed (PGE2 plus PGB2 plus PGA~). 
Discussion 
In searching for substances which might influence collagenase production by 
synovial cells we found that lymphocytes-monocytes  in culture released a factor 
which markedly increased collagenase produced by these cells  (10). A  factor 
which had a  similar pattern of elution from gel filtration columns also stimu- 
lated the PGE2 production by these cells. Indomethacin, the nonsteroidal anti- 
inflammatory  drug so far tested, inhibited PGE production but in most cultures DAYER  ET  AL.  BRIEF  DEFINITIVE  REPORT  1403 
did not inhibit  collagenase  production;  in  some cultures  even  stimulation  of 
collagenase production by LM in the presence of indomethacin was observed as 
was found with freshly isolated synodal cells.  In the presence of lymphocyte 
factor, while there was a striking stimulation of the production of both PGE2 and 
collagenase,  there was a  significant decrease in the number of synovial cells. 
This  suppression  of cell  growth  in  the  presence  of the  LM was  reversed by 
indomethacin, where production of PGE2 was also suppressed. It is possible that 
the  decrease in  cell  number  is due to  an  increase  in cellular  cAMP  (14).  In 
preliminary experiments we have found that PGE2, at concentrations similar to 
those measured in these experiments, acutely increases levels of cAMP in these 
synodal  cells  and  it  is  known  that  cAMP  inhibits  cell  division  in  several 
different systems (15).  The prostaglandins  released in increased concentration 
stimulated by the LM could also function in a negative feedback capacity in the 
immune system as has been shown for several lymphokines (16). 
The mechanism  of the stimulation  of two separate factors,  collagenase and 
prostaglandin by the lymphocyte factor is not known. It is conceivable that the 
PGE2 increase is accounted for either by increasing the availability of arachi- 
donate  or  by increasing  the  activity  of one  or  more  enzymatic  steps  on  the 
pathway of prostaglandin biosynthesis. 
Summary 
Human peripheral blood mononuclear cells (lymphocyte-monocyte) in culture 
release  a  soluble  factor  which  can  stimulate,  up  to  200-fold,  production  of 
prostaglandin E2 by isolated, adherent, rheumatoid synovial cells. Production of 
the factor by the mononuclear cells is enhanced by phytohemagglutinin.  This 
factor is similar in apparent mol wt (10,000-20,000) to that which also stimulates 
collagenase production by the same cells. 
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